An Exploratory Study of Cluster of Differentiation 38 (CD38) Monoclonal Antibody in Acquired Hemophilia A
Condition:   Acquired Hemophilia Intervention:   Drug: Daratumumab Sponsor:   Institute of Hematology & Blood Diseases Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 9, 2023 Category: Research Source Type: clinical trials